Search research articles
Contact Us
Filters
Showing results (331-340 of 408) with videos related to
Page
of 41
Sort By:
International Journal of Oncology
|
November 9, 2012
Asymmetric siRNA targeting the bcl‑2 gene inhibits the proliferation of cancer cells in vitro and in vivo
Yan Yin, Xu Chen, Chang-Dong Zhang, et al.
Journal of Surgical Oncology
|
June 4, 2014
Simultaneous diagnostic platform of genotyping EGFR, KRAS, and ALK in 510 Korean patients with non-small-cell lung cancer highlights significantly higher ALK rearrangement rate in advanced stage
Tae-Jung Kim, Chan Kwon Park, Chang Dong Yeo, et al.
Current Stem Cell Research & Therapy
|
May 12, 2025
HucMSCs-derived Exosomes Protect Against 6-hydroxydopamineinduced Parkinson's Disease in Rats by Inhibiting Caspase-3 Expression and Suppressing Apoptosis
Hong-Xu Chen, Hong-Jun Xu, Wang Zhang, et al.
Translational Lung Cancer Research
|
May 17, 2023
Current literature review on the tumor immune micro-environment, its heterogeneity and future perspectives in treatment of advanced non-small cell lung cancer
Jeong Uk Lim, Eunyoung Lee, Sang-Yun Lee, et al.
Biomedicines
|
February 26, 2025
Targeting the Tumor Microenvironment in EGFR-Mutant Lung Cancer: Opportunities and Challenges
Jeong Uk Lim, Junyang Jung, Yeon Wook Kim, et al.
BMC Cancer
|
September 5, 2020
Impact of smoking amount on clinicopathological features and survival in non-small cell lung cancer
Woo Ho Ban, Chang Dong Yeo, Solji Han, et al.
Bioscience, Biotechnology, and Biochemistry
|
March 9, 2010
Fangchinoline induced G1/S arrest by modulating expression of p27, PCNA, and cyclin D in human prostate carcinoma cancer PC3 cells and tumor xenograft
Chang-Dong Wang, Jian-Guo Huang, Xuan Gao, et al.
Therapeutic Advances in Medical Oncology
|
February 10, 2025
Comparative analysis of alectinib and brigatinib in real-world treatment of advanced NSCLC with ALK rearrangements
Kyuhwan Kim, Kyu Yean Kim, Hye Seon Kang, et al.
Thoracic Cancer
|
May 27, 2024
Real-world study of lazertinib as second-line or greater treatment in advanced non-small cell lung cancer
Jeong Uk Lim, Kyuhwan Kim, Kyu Yean Kim, et al.
International Immunopharmacology
|
December 29, 2009
Tetrandrine attenuates lipopolysaccharide-induced fulminant hepatic failure in D-galactosamine-sensitized mice
Xia Gong, Fu-ling Luo, Li Zhang, et al.
Page
of 41
Search research articles
Search
Showing results (331-340 of 408) with videos related to
Sort By:
Page
of 41
International Journal of Oncology
|
November 9, 2012
Asymmetric siRNA targeting the bcl‑2 gene inhibits the proliferation of cancer cells in vitro and in vivo
Yan Yin, Xu Chen, Chang-Dong Zhang, et al.
Journal of Surgical Oncology
|
June 4, 2014
Simultaneous diagnostic platform of genotyping EGFR, KRAS, and ALK in 510 Korean patients with non-small-cell lung cancer highlights significantly higher ALK rearrangement rate in advanced stage
Tae-Jung Kim, Chan Kwon Park, Chang Dong Yeo, et al.
Current Stem Cell Research & Therapy
|
May 12, 2025
HucMSCs-derived Exosomes Protect Against 6-hydroxydopamineinduced Parkinson's Disease in Rats by Inhibiting Caspase-3 Expression and Suppressing Apoptosis
Hong-Xu Chen, Hong-Jun Xu, Wang Zhang, et al.
Translational Lung Cancer Research
|
May 17, 2023
Current literature review on the tumor immune micro-environment, its heterogeneity and future perspectives in treatment of advanced non-small cell lung cancer
Jeong Uk Lim, Eunyoung Lee, Sang-Yun Lee, et al.
Biomedicines
|
February 26, 2025
Targeting the Tumor Microenvironment in EGFR-Mutant Lung Cancer: Opportunities and Challenges
Jeong Uk Lim, Junyang Jung, Yeon Wook Kim, et al.
BMC Cancer
|
September 5, 2020
Impact of smoking amount on clinicopathological features and survival in non-small cell lung cancer
Woo Ho Ban, Chang Dong Yeo, Solji Han, et al.
Bioscience, Biotechnology, and Biochemistry
|
March 9, 2010
Fangchinoline induced G1/S arrest by modulating expression of p27, PCNA, and cyclin D in human prostate carcinoma cancer PC3 cells and tumor xenograft
Chang-Dong Wang, Jian-Guo Huang, Xuan Gao, et al.
Therapeutic Advances in Medical Oncology
|
February 10, 2025
Comparative analysis of alectinib and brigatinib in real-world treatment of advanced NSCLC with ALK rearrangements
Kyuhwan Kim, Kyu Yean Kim, Hye Seon Kang, et al.
Thoracic Cancer
|
May 27, 2024
Real-world study of lazertinib as second-line or greater treatment in advanced non-small cell lung cancer
Jeong Uk Lim, Kyuhwan Kim, Kyu Yean Kim, et al.
International Immunopharmacology
|
December 29, 2009
Tetrandrine attenuates lipopolysaccharide-induced fulminant hepatic failure in D-galactosamine-sensitized mice
Xia Gong, Fu-ling Luo, Li Zhang, et al.
Page
of 41